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Abstract
© 2016, The Author(s).In this meeting report, particularly addressing the topic of protection of
the cardiovascular system from ischemia/reperfusion injury, highlights are presented that relate
to conditioning strategies of the heart with respect to molecular mechanisms and outcome in
patients’ cohorts, the influence of co-morbidities and medications, as well as the contribution of
innate  immune reactions  in  cardioprotection.  Moreover,  developmental  or  systems biology
approaches bear great potential in systematically uncovering unexpected components involved
in ischemia–reperfusion injury or heart regeneration. Based on the characterization of particular
platelet integrins, mitochondrial redox-linked proteins, or lipid-diol compounds in cardiovascular
diseases, their targeting by newly developed theranostics and technologies opens new avenues
for diagnosis and therapy of myocardial infarction to improve the patients’ outcome.
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